ParakkalDeepakMDMS

PubMed

• 3 citations
  Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses.
  Alessandro Armuzzi, Raymond K Cross, Gary R Lichtenstein, Jason Hou, Parakkal Deepak
  Clinical Gastroenterology and Hepatology. 2024-05-01
• 37 citations
  Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD - disease outcome and response to therapy
  Bram Verstockt, Nurulamin M Noor, Urko M. Marigorta, Polychronis Pavlidis, Parakkal Deepak
  Journal of Crohn's & Colitis. 2021-09-25
• 701 citations
  Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.
  Rita E. Chen, Xianwen Zhang, James Brett Case, Emma S. Winkler, Yang Liu
  Nature Medicine. 2021-04-01

Journal Articles

• Mucinous Small Bowel Adenocarcinoma Mimicking Change to Internal Penetrating Phenotype in Well-Controlled Crohn’s Disease  
  Parakkal Deepak, MD, Nature
• De-Novo Inflammatory Bowel Disease After Bariatric Surgery: A Large Case Series  
  Fateh Bazerbachi, David H Bruining, Vladimir M Kushnir, Meera Shah, Matthew A Ciorba, Laura E Raffals, Parakkal Deepak, Journal of Crohn's and Colitis
• Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumato...  
  Krishnan A, Stobaugh DJ, Deepak P, Rheumatol Int, 1/17/2014
• Effect of Tumor Necrosis Factor-alpha Inhibitors on Drug-Induced Pancreatitis in Inflammatory Bowel Disease  
  Stobaugh DJ, Deepak P, Ann Pharmacother, 1/1/2014
• Maternal and Fetal Adverse Events with Tumor Necrosis Factor alpha inhibitors in Inflammatory Bowel Disease  
  Deepak P, Stobaugh DJ, Aliment Pharmacol Ther, 1/1/2014
• Melanoma and non-Melanoma Skin Cancer in Inflammatory Bowel Disease Patients following Tumor Necrosis Factor-Alpha inhibitor Monotherapy and in Combination with Thiopu...  
  McKenna MR, Stobaugh DJ, Deepak P, J Gastrointestin Liver Dis, 1/1/2014
• The metoclopramide Black Box warning for tardive dyskinesia: Effect on clinical practice, adverse event reporting and prescription drug lawsuits The Red Section  
  Ehrenpreis ED, Deepak P, Sifuentes H, Devi R, Du H, Leikin JB, Am J Gastroenterol, 1/1/2013
• Neurological events with Tumor Necrosis Factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System  
  Deepak P, Stobaugh DJ, Sherid M, Sifuentes H, Ehrenpreis ED, Aliment Pharmacol Ther, 1/1/2013
• Alleged Isotretinoin-associated inflammatory bowel disease: Disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System  
  Stobaugh DJ, Deepak P, Ehrenpreis ED, J Am Acad Dermatol, 1/1/2013
• Ischemic Colitis in rheumatoid arthritis patients receiving tumor necrosis factor-alpha inhibitors: An analysis of reports to the US FDA Adverse Event Reporting System  
  Salk A, Stobaugh DJ, Deepak P, Ehrenpreis ED, Drug Saf, 1/1/2013
• Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: A six year analysis of the Nationwide Inpatient Sample  
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Clin Exp Gastroenterol, 1/1/2013
• Relationship between mesenteric abnormalities on computed tomography and malignancy: Clinical findings and outcomes of 359 Patients  
  Smith ZL, Sifuentes H, Deepak P, Ecanow D, Ehrenpreis ED, J Clin Gastroenterol, 1/1/2013
• Increased risk of osteoporosis related fractures in patients with irritable bowel syndrome  
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Osteoporos Int, 1/1/2013
• T-cell Non-Hodgkin lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-alpha) inhibitors: Results of the REFURBISH study  
  Deepak P, Sifuentes H, Sherid M, Stobaugh DJ, Sadozai Y, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• A simulated comparison of topical and oral formulations of 5-aminosalicylate for the treatment of ulcerative colitis  
  Stobaugh DJ, Deepak P, Thorpe M, Hannon B, Ehrenpreis ED, Inflamm Bowel Dis, 1/1/2013
• Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration...  
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Eur J Clin Pharmacol, 1/1/2013
• Use of polyethylene glycol (PEG)-based colonoscopy preparations before rectal argon plasma coagulation: Lessons still to be learnt by practicing gastroenterologists  
  Deepak P, Devi R, Sifuentes H, Ehrenpreis ED, J Clin Gastroenterol, 1/1/2012
• Lower body weight and female gender: Hyperphosphatemia risk factors after sodium phosphate preparation  
  Deepak P, Ehrenpreis ED, World J Gastroenterol, 1/7/2011
• Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor therapy: Expanding the groups at risk  
  Parakkal D, Sifuentes H, Semer R, Ehrenpreis ED, Eur J Gastroenterol Hepatol, 1/1/2011
• Esophageal small cell carcinoma with synchronous renal cell carcinoma: a case report with review of literature  
  Parakkal D, Devi R, Pillai H, Case Rep Gastroenterol, 1/1/2011
• Renal risks of sodium phosphate tablets for colonoscopy preparation: A review of adverse drug reactions (ADRs) reported to the Food and Drug Administration (FDA)  
  Ehrenpreis ED, Parakkal D, Semer R, Du H, Colorectal Dis, 1/1/2011
• A dynamic model of once-daily 5-aminosalicylic acid predicts clinical efficacy  
  Parakkal D, Ehrenpreis ED, Thorpe MP, Putt KS, Hannon B, World J Gastroenterol, 1/7/2010
• Calcium phosphate nephropathy from colonoscopy preparations: Effect of body weight  
  Parakkal D, Ehrenpreis ED, Am J Gastroenterol, 1/1/2010
• Join now to see all

Books/Book Chapters

• Gastroenterology & Hepatology Board Review (Pearls of Wisdom) 
  Chapter: Maldigestion and malabsorption. 
  Page 127 - 134Deepak P, Ehrenpreis EDEditors: DiBaise JK.McGraw-Hill, Columbus, OHEdition 3rd,2012
• Gastroenterology & Hepatology Board Review (Pearls of Wisdom) 
  Chapter: Gastrointestinal and hepatobiliary manifestations of HIV and AIDS. 
  Page 315 - 322Sifuentes H, Deepak P, Ehrenpreis EDEditors: DiBaise JK.McGraw-Hill, Columbus, OHEdition 3rd,2012
• Endoscopic Procedures in Colon and Rectum 
  Chapter: Preparing for colonoscopy. 
  Deepak P, Sifuentes H, Sherid M, Ehrenpreis EDEditors: Jose Joaquim Ribeiro da Rocha.InTech2011

Abstracts/Posters

• Diagnostic Yield of Chromoendoscopy and Outcomes in IBD Patients with History of Dysplasia.
  Hanson GJ, Deepak P, Fletcher JG, Tremaine WJ, Pardi DS, Kisiel JB, Schroeder KW, Loftus EV Jr, Bruining DH, Gastrointestinal Endoscopy, 1/1/2014
• Risk of Pancreatitis with Tumor Necrosis Factor-alpha Inhibitors among Iinflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Ev...
  Stobaugh DJ, Samo S, Deepak P, Ehrenpreis ED, Gastroenterology, 1/1/2014
• Diagnostic Yield of Chromoendoscopy and Outcomes in IBD Patients with History of Dysplasia.
  Hanson GJ, Deepak P, Fletcher JG, Tremaine WJ, Pardi DS, Kisiel JB, Schroeder KW, Loftus EV Jr, Bruining DH, Digestive Diseases Week, Chicago, IL, 1/1/2014
• Risk of Pancreatitis with Tumor Necrosis Factor-alpha Inhibitors among Iinflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Ev...
  Stobaugh DJ, Samo S, Deepak P, Ehrenpreis ED, Digestive Diseases Week, Chicago, IL, 1/1/2014
• Clinical characteristics and natural history of Crohn's disease patients with endoscopic skipping of distal terminal ileum on ileoscopy.
  Deepak P, Fletcher JG, Fidler JF, Samuel S, Loftus, EV Jr, Barlow JM, Hansel SL, Becker B, Mansuri II, Bruining DH, ACG Annual Scientific Meeting, Philadelphia, PA, 1/1/2014
• Endoscopic skipping of the distal terminal ileum in pediatric Crohn's disease.
  Mansuri II, Fletcher JG, Kolbe AB, Deepak P, Bruining DH, Fidler JF, Samuel S, Loftus EV Jr, Barlow JM, Hansel SL, Becker B, Tung J, ACG Annual Scientific Meeting, Philadelphia, PA, 1/1/2014
• Risk of Infections With Natalizumab Therapy Among Patients With Crohn's Disease: An Analysis of the Food and Drug Administration Adverse Event Reporting System.
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Risk of Leukemia With Pharmacotherapy Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System.
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Maternal and Fetal Adverse Outcomes With Tumor Necrosis Factor Alpha Inhibitors in Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration...
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Drug Induced Lupus (DIL) With Adalimumab and Certolizumab in Infliximab Naive Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adve...
  Deepak P, Stobaugh DJ, Riederman BD, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Risk of Solid Cancers With Tumor Necrosis Factor Alpha Inhibitor Therapy Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adv...
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Intestinal Adverse Outcomes With Pancreatic Enzymes: An Analysis of the Food and Drug Administration Adverse Event Reporting System.
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Risk of Melanoma and Non-Melanoma Skin Cancers With Pharmacotherapy Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse ...
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Gastroenterology, 1/1/2013
• A Predictive Model of the Risk of Developing Multiple Cancers With Tumor Necrosis Factor Alpha Inhibitor Therapy Among Patients With Inflammatory Bowel Disease.
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Gastroenterology, 1/1/2013
• A Computer-Fitted BiPhasic Emptying Model (CBEM) Increases the Yield of Scintigraphic Gastric Emptying (SGE) Studies in Children With Upper GI Symptoms.
  Ehrenpreis ED, Deepak P, Stobaugh DJ, Smith H, Saps M, Gastroenterology, 1/1/2013
• Analysis of the Food and Drug Administration Adverse Event Reporting System to examine the relationship between tumor necrosis factor alpha inhibitor therapy and conge...
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• Analysis of drug induced liver injury reported with Tumor Necrosis Factor-alpha inhibitors to the Food and Drug administration Adverse Event Reporting System in Inflam...
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• Safety of polyethylene glycol based preparations for bowel cleansing before colonoscopy: An analysis of the Food and Drug Administration Adverse Event Reporting System.
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• Comorbidity with depression is associated with increased length of stay and higher hospitalization charges in patients with inflammatory bowel disease.
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• An analysis of hospital charges and length of stay in patients with eosinophilic esophagitis, admitted for foreign body in the esophagus.
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• Effect of Comorbid Celiac Disease on Hospitalized Patients with Inflammatory Bowel Disease.
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• Maternal and fetal adverse outcomes with tumor necrosis factor alpha inhibitors in inflammatory bowel disease patients: An analysis of the Food and Drug Administration...
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Drug induced lupus (DIL) with adalimumab and certolizumab in infliximab naive inflammatory bowel disease patients: An analysis of the Food and Drug Administration Adve...
  Deepak P, Stobaugh DJ, Riederman BD, Ehrenpreis ED, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Risk of leukemia with pharmacotherapy among inflammatory bowel disease patients: An analysis of the Food and Drug Administration Adverse Event Reporting System.
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Risk of infections with natalizumab therapy among patients with Crohn's disease: An analysis of the Food and Drug Administration Adverse Event Reporting System.
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Join now to see all

Lectures

• Pharmacotherapy and invasive fungal infections in patients receiving TNF-alpha blockers, immunomodulators and systemic corticosteroids: A review of the Food and Drug A... 
  San Diego, CA - 1/1/2012
• Disproportionate lawyer reporting of inflammatory bowel disease cases with isotretinoin: A review of the Food and Drug Administration (FDA) Adverse Event Reporting Sys... 
  Las Vegas, NV - 1/1/2012

Other

• Gastritis. 
  Ehrenpreis ED, Eichenwald E, Deepak P, BMJ Point of Care Series and Epocrates
  https://online.epocrates.com/u/2961816/Gastritis
  1/4/2011
• National Organization for Rare Diseases (NORD) 2011 rare disease report on sclerosing mesenteritis. 
  Ehrenpreis ED, Deepak P